CEBPA and focal segmental glomerulosclerosis: In order to assess whether the decreased expression of C/EBP-α in the setting of glomerular injury affected the disease progression, we generated a podocyte-specific knockout of C/EBP-α and challenged them with Adriamycin (ADR)-induced injury, an experimental model of FSGS.